Zheng J, Wang H, Wu W, Wang L, Qin M, Zhu L
J Neuroinflammation. 2025; 22(1):79.
PMID: 40083006
PMC: 11907847.
DOI: 10.1186/s12974-025-03408-4.
Fumagalli I, Parolini N, Verani M
J Sci Comput. 2025; 103(1):22.
PMID: 40065827
PMC: 11890245.
DOI: 10.1007/s10915-025-02814-3.
Izhar M, Thakur A, Park D, Chang S
J Liq Biopsy. 2025; 6:100277.
PMID: 40027314
PMC: 11863884.
DOI: 10.1016/j.jlb.2024.100277.
Liu J, Wang T, Dong J, Lu Y
J Nanobiotechnology. 2025; 23(1):146.
PMID: 40011926
PMC: 11866817.
DOI: 10.1186/s12951-025-03247-8.
Boreski D, Schmid V, Bosquesi P, Dos Santos J, Scarim C, Reshetnikov V
Pharmaceuticals (Basel). 2025; 18(2).
PMID: 40006024
PMC: 11859331.
DOI: 10.3390/ph18020210.
Transcriptional Responses of In Vitro Blood-Brain Barrier Models to Shear Stress.
Foreman K, Gastfriend B, Katt M, Palecek S, Shusta E
Biomolecules. 2025; 15(2).
PMID: 40001496
PMC: 11853657.
DOI: 10.3390/biom15020193.
Cancer brain metastasis: molecular mechanisms and therapeutic strategies.
Lu Y, Huang Y, Zhu C, Li Z, Zhang B, Sheng H
Mol Biomed. 2025; 6(1):12.
PMID: 39998776
PMC: 11861501.
DOI: 10.1186/s43556-025-00251-0.
Toward the Treatment of Glioblastoma Tumors Using Photoactivated Chemotherapy: In Vitro Evaluation of Efficacy and Safety.
Goetzfried S, Hakkennes M, Busemann A, Bonnet S
ACS Pharmacol Transl Sci. 2025; 8(2):484-498.
PMID: 39974641
PMC: 11833736.
DOI: 10.1021/acsptsci.4c00600.
Alanine and glutathione targeting of dopamine- or ibuprofen-coupled polypeptide nanocarriers increases both crossing and protective effects on a blood-brain barrier model.
Meszaros M, Phan T, Vigh J, Porkolab G, Kocsis A, Szecsko A
Fluids Barriers CNS. 2025; 22(1):18.
PMID: 39972353
PMC: 11837687.
DOI: 10.1186/s12987-025-00623-2.
Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology.
Dhariwal R, Jain M, Mir Y, Singh A, Jain B, Kumar P
Front Med (Lausanne). 2025; 12:1522223.
PMID: 39963432
PMC: 11831571.
DOI: 10.3389/fmed.2025.1522223.
Something to talk about; crosstalk disruption at the neurovascular unit during HIV infection of the CNS.
Galpayage Dona K, Benmassaoud M, Gipson C, McLaughlin J, Ramirez S, Andrews A
NeuroImmune Pharm Ther. 2025; 3(2):97-111.
PMID: 39958876
PMC: 11823645.
DOI: 10.1515/nipt-2024-0003.
Rosuvastatin mitigates blood-brain barrier disruption in sepsis-associated encephalopathy by restoring occludin levels.
Shen Q, Yu Q, Chen T, Zhang L
Eur J Med Res. 2025; 30(1):103.
PMID: 39953583
PMC: 11827257.
DOI: 10.1186/s40001-025-02314-y.
Melatonin Mitigates Acidosis-Induced Neuronal Damage by Up-Regulating Autophagy via the Transcription Factor EB.
Shi Y, Mi Z, Zhao W, Hu Y, Xiang H, Gan Y
Int J Mol Sci. 2025; 26(3).
PMID: 39940940
PMC: 11818126.
DOI: 10.3390/ijms26031170.
Blood-Brain Barrier Disruption in Schizophrenia: Insights, Mechanisms, and Future Directions.
Zhang F, Zhang J, Wang X, Han M, Fei Y, Wang J
Int J Mol Sci. 2025; 26(3).
PMID: 39940642
PMC: 11817713.
DOI: 10.3390/ijms26030873.
Choroid plexus organoids reveal mechanisms of Streptococcus suis translocation at the blood-cerebrospinal fluid barrier.
Zhao T, Pellegrini L, van der Hee B, Boekhorst J, Fernandes A, Brugman S
Fluids Barriers CNS. 2025; 22(1):14.
PMID: 39930492
PMC: 11812244.
DOI: 10.1186/s12987-025-00627-y.
Prediction of the Extent of Blood-Brain Barrier Transport Using Machine Learning and Integration into the LeiCNS-PK3.0 Model.
Gulave B, van den Maagdenberg H, van Boven L, van Westen G, de Lange E, van Hasselt J
Pharm Res. 2025; 42(2):281-289.
PMID: 39930309
PMC: 11880073.
DOI: 10.1007/s11095-025-03828-0.
Driver mutation detected in cerebrospinal fluid despite negative liquid biopsy results.
Kunimasa K, Aohara D, Nishino K
Discov Oncol. 2025; 16(1):145.
PMID: 39928192
PMC: 11811313.
DOI: 10.1007/s12672-025-01931-7.
A Site-Specific MiniAp4-Trastuzumab Conjugate Prevents Brain Metastasis.
Masmudi-Martin M, Oller-Salvia B, Perea M, Teixido M, Valiente M, Giralt E
Mol Pharm. 2025; 22(3):1384-1395.
PMID: 39924896
PMC: 11881140.
DOI: 10.1021/acs.molpharmaceut.4c01091.
Yin Yang 1: Function, Mechanisms, and Glia.
Rodriguez-Campuzano A, Castelan F, Hernandez-Kelly L, Felder-Schmittbuhl M, Ortega A
Neurochem Res. 2025; 50(2):96.
PMID: 39904836
PMC: 11794380.
DOI: 10.1007/s11064-025-04345-7.
Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system.
Luo Q, Yang J, Yang M, Wang Y, Liu Y, Liu J
Mater Today Bio. 2025; 31:101457.
PMID: 39896289
PMC: 11786670.
DOI: 10.1016/j.mtbio.2025.101457.